Safety of Tildrakizumab in Psoriatic Arthritis: An Interim Analysis from a Randomized, Double-blind, Placebo-controlled Phase 2b Trial

被引：0
|
作者：
Ritchlin, Christopher [1 ]
Strand, Vibeke [2 ]
Ballerini, Rocco [3 ]
Chou, Richard C. [4 ]
Rozzo, Stephen [3 ]
Mendelsohn, Alan [3 ]
Kavanaugh, Arthur [5 ]
机构：
[1] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Div Allergy Immunol & Rheumatol, Rochester, NY USA
[2] Stanford Univ, Sch Med, Div Immunol Rheumatol, Palo Alto, CA 94304 USA
[3] Sun Pharmaceut Ind Inc, Princeton, NJ USA
[4] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA
[5] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1525
引用
收藏
页数：3
相关论文
共 50 条
  • [31] EFRUXIFERMIN IN COMPENSATED CIRRHOSIS DUE TO NASH/MASH: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2b TRIAL (SYMMETRY)
    Harrison, Stephen A.
    Neff, Guy W.
    Lucas, Kathryn Jean
    Rodriguez, Manuel
    Wofford, Scott
    Benun, Jacques
    Rudraraju, Madhavi
    Noureddin, Mazen
    Su, Yan
    Chan, Doreen
    Zari, Arian
    De Temple, Brittany
    Shringarpure, Reshma
    Tillman, Erik
    Rolph, Timothy P.
    Cheng, Andrew
    Yale, Kitty
    HEPATOLOGY, 2024, 79 (02) : E37 - E39
  • [32] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
    Butchart, Joseph
    Brook, Laura
    Hopkins, Vivienne
    Teeling, Jessica
    Puentener, Ursula
    Culliford, David
    Sharples, Richard
    Sharif, Saif
    McFarlane, Brady
    Raybould, Rachel
    Thomas, Rhodri
    Passmore, Peter
    Perry, V. Hugh
    Holmes, Clive
    NEUROLOGY, 2015, 84 (21) : 2161 - 2168
  • [33] Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study of Ecopipam in Children and Adolescents with Tourette Syndrome
    Mahableshwarkar, A.
    Dubow, J.
    Cunniff, T.
    Wanaski, S.
    MOVEMENT DISORDERS, 2022, 37 : S415 - S415
  • [34] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL
    Tufan, Ayse N.
    Tufan, Fatih
    NEUROLOGY, 2015, 85 (23) : 2083 - 2084
  • [35] SULFASALAZINE IN PSORIATIC-ARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    FARR, M
    KITAS, GD
    WATERHOUSE, L
    JUBB, R
    FELIXDAVIES, D
    BACON, PA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (01): : 46 - 49
  • [36] Efficacy and Safety of Tildrakizumab, a High-Affinity Anti-Interleukin-23p19 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis in a Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2b Study
    Mease, Philip
    Chohan, Saima
    Garcia Fructuoso, Ferran J.
    Gottlieb, Alice
    Luggen, Michael
    Rahman, Proton
    Raychaudhuri, Siba
    Chou, Richard
    Mendelsohn, Alan
    Rozzo, Stephen
    Orbai, Ana-Maria
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [37] Randomized, double-blind, placebo-controlled, multiple-dose, phase 2b study to demonstrate the safety and efficacy of tildrakizumab, a high-affinity antieinterleukin-23p19 monoclonal antibody, in patients with active psoriatic arthritis
    Mease, Philip J.
    Chohan, Saima
    Garcia Fructuoso, Ferran J.
    Gottlieb, Alice B.
    Chou, Richard
    Mendelsohn, Alan M.
    Ballerini, Rocco
    Luggen, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB165 - AB165
  • [38] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [39] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
    Leber, Andrew
    Hontecillas, Raquel
    Juni, Nuria Tubau
    Bassaganya-Riera, Josep
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S821 - S821
  • [40] Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
    Hanna, Michael G.
    Badrising, Umesh A.
    Benveniste, Olivier
    Lloyd, Thomas E.
    Needham, Merrilee
    Chinoy, Hector
    Aoki, Masashi
    Machado, Pedro M.
    Liang, Christina
    Reardon, Katrina A.
    de Visser, Marianne
    Ascherman, Dana P.
    Barohn, Richard J.
    Dimachkie, Mazen M.
    Miller, James A. L.
    Kissel, John T.
    Oskarsson, Bjoern
    Joyce, Nanette C.
    Van den Bergh, Peter
    Baets, Jonathan
    De Bleecker, Jan L.
    Karam, Chafic
    David, William S.
    Mirabella, Massimiliano
    Nations, Sharon P.
    Jung, Hans H.
    Pegoraro, Elena
    Maggi, Lorenzo
    Rodolico, Carmelo
    Filosto, Massimiliano
    Shaibani, Aziz, I
    Sivakumar, Kumaraswamy
    Goyal, Namita A.
    Mori-Yoshimura, Madoka
    Yamashita, Satoshi
    Suzuki, Naoki
    Katsuno, Masahisa
    Murata, Kenya
    Nodera, Hiroyuki
    Romano, Carla D.
    Williams, Valerie S. L.
    Vissing, John
    Auberson, Lixin Zhang
    Wu, Min
    de Vera, Ana
    Papanicolaou, Dimitris A.
    Amato, Anthony A.
    Nishino, Ichizo
    LANCET NEUROLOGY, 2019, 18 (09): : 834 - 844
12345